Healthcare TechnologyNVIDIA BioNeMo Platform Deployed by Global Pharma Giants for AI Drug Discovery in 2026Salvado•Apr 9, 2026
health-techNVIDIA's Drug Discovery AI Platform Secures Eli Lilly, Thermo Fisher Partnerships Across Three ContinentsSalvado•Mar 29, 2026
Healthcare AINVIDIA BioNeMo Platform Secures Eli Lilly and Thermo Fisher Partnerships for AI Drug Discovery InfrastructureSalvado•Mar 26, 2026
Healthcare TechnologyNVIDIA's AI Platform Powers Drug Discovery at Thermo Fisher, Eli Lilly in $1.6 Trillion Pharma Market PushSalvado•Mar 25, 2026
Healthcare TechnologyNVIDIA BioNeMo Platform Adopted by Eli Lilly and Thermo Fisher for AI Drug DiscoverySalvado•Mar 23, 2026
BiotechNVIDIA BioNeMo Platform Gains Thermo Fisher and Eli Lilly Adoption as Biological AI Market ExpandsSalvado•Mar 22, 2026
Science & TechnologyNVIDIA's BioNeMo Aims to Become the Global Infrastructure Layer for Drug DiscoveryViaNews Editorial Team•Feb 18, 2026
Science & TechnologyNVIDIA's BioNeMo Positions AI as the New Global Lab Infrastructure in Race to Reinvent Drug DiscoveryViaNews Editorial Team•Feb 18, 2026
Science & TechnologyNVIDIA's BioNeMo Bets on Becoming the Global Infrastructure Layer for Pharmaceutical AIViaNews Editorial Team•Feb 18, 2026
AnalysisNVIDIA Targets Drug Discovery Market With AI Infrastructure PushViaNews Editorial Team•Feb 15, 2026
